HIGHLIGHTS
- who: Anneleen Berende and collaborators from the Department of Internal Medicine, and Radboud Center for Infectious Diseases, Radboud University Medical have published the Article: Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0195260]. April 2, 2018 of /1371/
- what: From a societal perspective, the longer-term treatments of ceftriaxone combined with doxycycline or with clarithromycin and hydroxychloroquine were as costly, effective and cost-effective as shorter-term treatment with ceftriaxone only . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.